Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 937 to 942 of 942 entries
Sorted by: Best Match Show Resources per page
Development of growth factor-incorporating liposomes for integration into scaffolds as a method to improve tissue regeneration.

The International journal of developmental biology

Natsaridis E, Mouzoura P, Gkartziou F, Marazioti A, Antimisiaris SG.
PMID: 34549789
Int J Dev Biol. 2021 Aug 09; doi: 10.1387/ijdb.210108sa. Epub 2021 Aug 09.

This review is an update about the efforts to develop liposomal carriers for growth factor delivery. It is well known that growth factors have the potential to enhance/accelerate tissue regeneration, however their poor stability which results in rapid loss...

Cite
Natsaridis E, Mouzoura P, Gkartziou F, et al. Development of growth factor-incorporating liposomes for integration into scaffolds as a method to improve tissue regeneration. Int J Dev Biol. 2021;doi: 10.1387/ijdb.210108sa.
Natsaridis, E., Mouzoura, P., Gkartziou, F., Marazioti, A., & Antimisiaris, S. G. (2021). Development of growth factor-incorporating liposomes for integration into scaffolds as a method to improve tissue regeneration. The International journal of developmental biology, . https://doi.org/10.1387/ijdb.210108sa
Natsaridis, E, et al. "Development of growth factor-incorporating liposomes for integration into scaffolds as a method to improve tissue regeneration." The International journal of developmental biology vol. (2021). doi: https://doi.org/10.1387/ijdb.210108sa
Natsaridis E, Mouzoura P, Gkartziou F, Marazioti A, Antimisiaris SG. Development of growth factor-incorporating liposomes for integration into scaffolds as a method to improve tissue regeneration. Int J Dev Biol. 2021 Aug 09; doi: 10.1387/ijdb.210108sa. Epub 2021 Aug 09. PMID: 34549789.
Copy Download .nbib Format: NLM
Importance of Nano Medicine and New Drug Therapies for Cancer.

Advanced pharmaceutical bulletin

Abdolmaleki A, Asadi A, Gurushankar K, Karimi Shayan T, Abedi Sarvestani F.
PMID: 34513619
Adv Pharm Bull. 2021 May;11(3):450-457. doi: 10.34172/apb.2021.052. Epub 2020 Oct 19.

Cancer is one of the deadly diseases leading to approximately 7.6 million deaths worldwide, with the mortality rate of 13%, and the number of deaths is expected to increase to 13.1 million within the next 10 years. In controlled...

Cite
Abdolmaleki A, Asadi A, Gurushankar K, et al. Importance of Nano Medicine and New Drug Therapies for Cancer. Adv Pharm Bull. 2020;11(3):450-457doi: 10.34172/apb.2021.052.
Abdolmaleki, A., Asadi, A., Gurushankar, K., Karimi Shayan, T., & Abedi Sarvestani, F. (2021). Importance of Nano Medicine and New Drug Therapies for Cancer. Advanced pharmaceutical bulletin, 11(3), 450-457. https://doi.org/10.34172/apb.2021.052
Abdolmaleki, Arash, et al. "Importance of Nano Medicine and New Drug Therapies for Cancer." Advanced pharmaceutical bulletin vol. 11,3 (2021): 450-457. doi: https://doi.org/10.34172/apb.2021.052
Abdolmaleki A, Asadi A, Gurushankar K, Karimi Shayan T, Abedi Sarvestani F. Importance of Nano Medicine and New Drug Therapies for Cancer. Adv Pharm Bull. 2021 May;11(3):450-457. doi: 10.34172/apb.2021.052. Epub 2020 Oct 19. PMID: 34513619; PMCID: PMC8421622.
Copy Download .nbib Format: NLM
Microfluidic mixing system for precise PLGA-PEG nanoparticles size control.

Nanomedicine : nanotechnology, biology, and medicine

Gimondi S, Guimarães CF, Vieira SF, Gonçalves VMF, Tiritan ME, Reis RL, Ferreira H, Neves NM.
PMID: 34748958
Nanomedicine. 2021 Nov 05;40:102482. doi: 10.1016/j.nano.2021.102482. Epub 2021 Nov 05.

In this study, a microfluidic device was employed to produce polymeric nanoparticles (NPs) with well-controlled sizes. The influence of several parameters in the synthesis process, namely, polymer concentration, flow rate and flow rate ratio between the aqueous and organic...

Cite
Gimondi S, Guimarães CF, Vieira SF, et al. Microfluidic mixing system for precise PLGA-PEG nanoparticles size control. Nanomedicine. 2021;40:102482doi: 10.1016/j.nano.2021.102482.
Gimondi, S., Guimarães, C. F., Vieira, S. F., Gonçalves, V. M. F., Tiritan, M. E., Reis, R. L., Ferreira, H., & Neves, N. M. (2021). Microfluidic mixing system for precise PLGA-PEG nanoparticles size control. Nanomedicine : nanotechnology, biology, and medicine, 40102482. https://doi.org/10.1016/j.nano.2021.102482
Gimondi, Sara, et al. "Microfluidic mixing system for precise PLGA-PEG nanoparticles size control." Nanomedicine : nanotechnology, biology, and medicine vol. 40 (2021): 102482. doi: https://doi.org/10.1016/j.nano.2021.102482
Gimondi S, Guimarães CF, Vieira SF, Gonçalves VMF, Tiritan ME, Reis RL, Ferreira H, Neves NM. Microfluidic mixing system for precise PLGA-PEG nanoparticles size control. Nanomedicine. 2021 Nov 05;40:102482. doi: 10.1016/j.nano.2021.102482. Epub 2021 Nov 05. PMID: 34748958.
Copy Download .nbib Format: NLM
Design and Synthesis of Lactose, Galactose and Cholic Acid Related Dual Conjugated Chitosan Derivatives as Potential Anti Liver Cancer Drug Carriers.

Polymers

Ding Y, Cui W, Vara Prasad CVNS, Wang B.
PMID: 34502978
Polymers (Basel). 2021 Aug 31;13(17). doi: 10.3390/polym13172939.

Cholic acid and galactose or lactose dual conjugated chitosan derivatives were designed and synthesized as potential anti liver cancer drug carriers, their structures were characterized through proton NMR spectra, elemental analysis, size distribution, zeta potential, and scanning electron microscope...

Cite
Ding Y, Cui W, Vara Prasad CVNS, et al. Design and Synthesis of Lactose, Galactose and Cholic Acid Related Dual Conjugated Chitosan Derivatives as Potential Anti Liver Cancer Drug Carriers. Polymers (Basel). 2021;13(17)doi: 10.3390/polym13172939.
Ding, Y., Cui, W., Vara Prasad, C. V. N. S., & Wang, B. (2021). Design and Synthesis of Lactose, Galactose and Cholic Acid Related Dual Conjugated Chitosan Derivatives as Potential Anti Liver Cancer Drug Carriers. Polymers, 13(17), . https://doi.org/10.3390/polym13172939
Ding, Yili, et al. "Design and Synthesis of Lactose, Galactose and Cholic Acid Related Dual Conjugated Chitosan Derivatives as Potential Anti Liver Cancer Drug Carriers." Polymers vol. 13,17 (2021). doi: https://doi.org/10.3390/polym13172939
Ding Y, Cui W, Vara Prasad CVNS, Wang B. Design and Synthesis of Lactose, Galactose and Cholic Acid Related Dual Conjugated Chitosan Derivatives as Potential Anti Liver Cancer Drug Carriers. Polymers (Basel). 2021 Aug 31;13(17). doi: 10.3390/polym13172939. PMID: 34502978; PMCID: PMC8433812.
Copy Download .nbib Format: NLM
Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery.

ISRN pharmaceutics

Kumar D, Sharma D, Singh G, Singh M, Rathore MS.
PMID: 22888455
ISRN Pharm. 2012;2012:474830. doi: 10.5402/2012/474830. Epub 2012 Jul 19.

Lipid-based innovations have achieved new heights during the last few years as an essential component of drug development. The current challenge of drug delivery is liberation of drug agents at the right time in a safe and reproducible manner...

Cite
Kumar D, Sharma D, Singh G, et al. Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery. ISRN Pharm. 2012;2012:474830doi: 10.5402/2012/474830.
Kumar, D., Sharma, D., Singh, G., Singh, M., & Rathore, M. S. (2012). Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery. ISRN pharmaceutics, 2012474830. https://doi.org/10.5402/2012/474830
Kumar, Dinesh, et al. "Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery." ISRN pharmaceutics vol. 2012 (2012): 474830. doi: https://doi.org/10.5402/2012/474830
Kumar D, Sharma D, Singh G, Singh M, Rathore MS. Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery. ISRN Pharm. 2012;2012:474830. doi: 10.5402/2012/474830. Epub 2012 Jul 19. PMID: 22888455; PMCID: PMC3409530.
Copy Download .nbib Format: NLM
PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery.

Advanced healthcare materials

Sheffey VV, Siew EB, Tanner EEL, Eniola-Adefeso O.
PMID: 35032406
Adv Healthc Mater. 2022 Jan 15;e2101536. doi: 10.1002/adhm.202101536. Epub 2022 Jan 15.

Numerous human disorders can benefit from targeted, intravenous (IV) drug delivery. Polymeric nanoparticles have been designed to undergo systemic circulation and deliver their therapeutic cargo to target sites in a controlled manner. Poly(lactic-co-glycolic) acid (PLGA) is a particularly promising...

Cite
Sheffey VV, Siew EB, Tanner EEL, et al. PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery. Adv Healthc Mater. 2022;e2101536doi: 10.1002/adhm.202101536.
Sheffey, V. V., Siew, E. B., Tanner, E. E. L., & Eniola-Adefeso, O. (2022). PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery. Advanced healthcare materials, e2101536. https://doi.org/10.1002/adhm.202101536
Sheffey, Violet V, et al. "PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery." Advanced healthcare materials vol. (2022): e2101536. doi: https://doi.org/10.1002/adhm.202101536
Sheffey VV, Siew EB, Tanner EEL, Eniola-Adefeso O. PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery. Adv Healthc Mater. 2022 Jan 15;e2101536. doi: 10.1002/adhm.202101536. Epub 2022 Jan 15. PMID: 35032406.
Copy Download .nbib Format: NLM
Showing 937 to 942 of 942 entries